Research Overview: Spectre Labs MK-2866 OSTARINE
The Spectre Labs MK-2866 OSTARINE 15mg & LGD-4033 LIGANDROL 10mg combination represents an advanced dual SARM formulation for sophisticated tissue-selective androgen receptor research. MK-2866 (Ostarine/Enobosarm) is a non-steroidal aryl-propionamide SARM with CAS number 841205-47-8, whilst LGD-4033 (Ligandrol) is a non-steroidal SARM with CAS 1165910-22-4. This pairing allows researchers at Stroid UK Shop to investigate complementary androgenic pathways in controlled laboratory environments. Both compounds demonstrate selective androgen receptor modulation with distinct binding affinities and tissue selectivity profiles in preclinical models.
Laboratory Applications
Researchers studying muscle biology can examine the synergistic effects of combining Ostarine’s well-documented anabolic properties with Ligandrol’s high-affinity androgen receptor binding. MK-2866 has been investigated in over 25 clinical studies involving 1,700+ subjects for cancer-related cachexia and sarcopenia research. LGD-4033 advanced through Phase I clinical trials and demonstrates pronounced anabolic activity in muscle tissue with reduced androgenic effects on prostate tissue in animal models. Scientists can evaluate the combined molecular mechanisms across our comprehensive SARMs mix collection alongside individual compounds from our SARMs category. This formulation provides researchers with standardised dosing protocols for investigating tissue-specific androgenic responses and comparing efficacy profiles against established research compounds available in our peptides section.
Technical Specifications
| Parameter | MK-2866 | LGD-4033 |
|---|---|---|
| Concentration | 15mg per capsule | 10mg per capsule |
| Molecular Formula | C₁₉H₁₄F₃N₃O₃ | C₁₄H₁₂F₆N₂O |
| Molecular Weight | 389.33 g/mol | 338.25 g/mol |
| CAS Number | 841205-47-8 | 1165910-22-4 |
| Storage | Room temperature, dry environment | |
| Shelf Life | 24 months from manufacture | |
Research Compliance
This Spectre Labs dual SARM formulation is manufactured exclusively for in-vitro laboratory research purposes. The product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure appropriate laboratory protocols, safety measures, and institutional oversight when handling these compounds. All studies should be conducted by qualified personnel within accredited research facilities.
